Copyright Reports & Markets. All rights reserved.

Global Hemoglobin A1c Monitoring Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Hemoglobin A1c Monitoring Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Ion-exchange
      • 1.4.3 High-performance liquid chromatography (HPLC)
      • 1.4.4 Immunoassay
      • 1.4.5 Boronate affinity chromatography
      • 1.4.6 Direct enzymatic assay
    • 1.5 Market by Application
      • 1.5.1 Global Hemoglobin A1c Monitoring Market Share by Application (2014-2025)
      • 1.5.2 HbA1c Laboratory Testing
      • 1.5.3 HbA1c Point of Care Testing
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Hemoglobin A1c Monitoring Market Size
    • 2.2 Hemoglobin A1c Monitoring Growth Trends by Regions
      • 2.2.1 Hemoglobin A1c Monitoring Market Size by Regions (2014-2025)
      • 2.2.2 Hemoglobin A1c Monitoring Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Hemoglobin A1c Monitoring Market Size by Manufacturers
      • 3.1.1 Global Hemoglobin A1c Monitoring Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Hemoglobin A1c Monitoring Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Hemoglobin A1c Monitoring Market Concentration Ratio (CR5 and HHI)
    • 3.2 Hemoglobin A1c Monitoring Key Players Head office and Area Served
    • 3.3 Key Players Hemoglobin A1c Monitoring Product/Solution/Service
    • 3.4 Date of Enter into Hemoglobin A1c Monitoring Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Hemoglobin A1c Monitoring Market Size by Type (2014-2019)
    • 4.2 Global Hemoglobin A1c Monitoring Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Hemoglobin A1c Monitoring Market Size (2014-2019)
    • 5.2 Hemoglobin A1c Monitoring Key Players in United States
    • 5.3 United States Hemoglobin A1c Monitoring Market Size by Type
    • 5.4 United States Hemoglobin A1c Monitoring Market Size by Application

    6 Europe

    • 6.1 Europe Hemoglobin A1c Monitoring Market Size (2014-2019)
    • 6.2 Hemoglobin A1c Monitoring Key Players in Europe
    • 6.3 Europe Hemoglobin A1c Monitoring Market Size by Type
    • 6.4 Europe Hemoglobin A1c Monitoring Market Size by Application

    7 China

    • 7.1 China Hemoglobin A1c Monitoring Market Size (2014-2019)
    • 7.2 Hemoglobin A1c Monitoring Key Players in China
    • 7.3 China Hemoglobin A1c Monitoring Market Size by Type
    • 7.4 China Hemoglobin A1c Monitoring Market Size by Application

    8 Japan

    • 8.1 Japan Hemoglobin A1c Monitoring Market Size (2014-2019)
    • 8.2 Hemoglobin A1c Monitoring Key Players in Japan
    • 8.3 Japan Hemoglobin A1c Monitoring Market Size by Type
    • 8.4 Japan Hemoglobin A1c Monitoring Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Hemoglobin A1c Monitoring Market Size (2014-2019)
    • 9.2 Hemoglobin A1c Monitoring Key Players in Southeast Asia
    • 9.3 Southeast Asia Hemoglobin A1c Monitoring Market Size by Type
    • 9.4 Southeast Asia Hemoglobin A1c Monitoring Market Size by Application

    10 India

    • 10.1 India Hemoglobin A1c Monitoring Market Size (2014-2019)
    • 10.2 Hemoglobin A1c Monitoring Key Players in India
    • 10.3 India Hemoglobin A1c Monitoring Market Size by Type
    • 10.4 India Hemoglobin A1c Monitoring Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Hemoglobin A1c Monitoring Market Size (2014-2019)
    • 11.2 Hemoglobin A1c Monitoring Key Players in Central & South America
    • 11.3 Central & South America Hemoglobin A1c Monitoring Market Size by Type
    • 11.4 Central & South America Hemoglobin A1c Monitoring Market Size by Application

    12 International Players Profiles

    • 12.1 Bayer Healthcare Diabetes Care (US)
      • 12.1.1 Bayer Healthcare Diabetes Care (US) Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Hemoglobin A1c Monitoring Introduction
      • 12.1.4 Bayer Healthcare Diabetes Care (US) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
      • 12.1.5 Bayer Healthcare Diabetes Care (US) Recent Development
    • 12.2 Abbott Laboratories (US)
      • 12.2.1 Abbott Laboratories (US) Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Hemoglobin A1c Monitoring Introduction
      • 12.2.4 Abbott Laboratories (US) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
      • 12.2.5 Abbott Laboratories (US) Recent Development
    • 12.3 Roche Diagnostics (Switzerland)
      • 12.3.1 Roche Diagnostics (Switzerland) Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Hemoglobin A1c Monitoring Introduction
      • 12.3.4 Roche Diagnostics (Switzerland) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
      • 12.3.5 Roche Diagnostics (Switzerland) Recent Development
    • 12.4 Axis-Shield plc (UK)
      • 12.4.1 Axis-Shield plc (UK) Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Hemoglobin A1c Monitoring Introduction
      • 12.4.4 Axis-Shield plc (UK) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
      • 12.4.5 Axis-Shield plc (UK) Recent Development
    • 12.5 Beckman Coulter, Inc. (US)
      • 12.5.1 Beckman Coulter, Inc. (US) Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Hemoglobin A1c Monitoring Introduction
      • 12.5.4 Beckman Coulter, Inc. (US) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
      • 12.5.5 Beckman Coulter, Inc. (US) Recent Development
    • 12.6 Bio-Rad Laboratories Inc (US)
      • 12.6.1 Bio-Rad Laboratories Inc (US) Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Hemoglobin A1c Monitoring Introduction
      • 12.6.4 Bio-Rad Laboratories Inc (US) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
      • 12.6.5 Bio-Rad Laboratories Inc (US) Recent Development
    • 12.7 Diazyme Laboratories Inc. (US)
      • 12.7.1 Diazyme Laboratories Inc. (US) Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Hemoglobin A1c Monitoring Introduction
      • 12.7.4 Diazyme Laboratories Inc. (US) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
      • 12.7.5 Diazyme Laboratories Inc. (US) Recent Development
    • 12.8 EKF Diagnostics Holdings Plc (UK)
      • 12.8.1 EKF Diagnostics Holdings Plc (UK) Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Hemoglobin A1c Monitoring Introduction
      • 12.8.4 EKF Diagnostics Holdings Plc (UK) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
      • 12.8.5 EKF Diagnostics Holdings Plc (UK) Recent Development
    • 12.9 HEMOCUE(r) AB (Sweden)
      • 12.9.1 HEMOCUE(r) AB (Sweden) Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Hemoglobin A1c Monitoring Introduction
      • 12.9.4 HEMOCUE(r) AB (Sweden) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
      • 12.9.5 HEMOCUE(r) AB (Sweden) Recent Development
    • 12.10 Infopia Co. Ltd. (South Korea)
      • 12.10.1 Infopia Co. Ltd. (South Korea) Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Hemoglobin A1c Monitoring Introduction
      • 12.10.4 Infopia Co. Ltd. (South Korea) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
      • 12.10.5 Infopia Co. Ltd. (South Korea) Recent Development
    • 12.11 Menarini Diagnostics Ltd. (UK)
    • 12.12 Siemens Healthcare Diagnostics (Germany)
    • 12.13 Tosoh Bioscience, Inc (US)
    • 12.14 Trinity Biotech plc (Ireland)
    • 12.15 ARKRAY, Inc. (Japan)

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      An A1C test is a blood test that reflects your average blood glucose levels over the past 3 months. The A1C test is sometimes called the hemoglobin A1C, HbA1c, glycated hemoglobin, or glycohemoglobin test. Hemoglobin is the part of a red blood cell that carries oxygen to the cells.
      Determining glycated hemoglobin levels assure healthcare professionals about the patient’s blood glucose levels. This test is used for diagnosing and monitoring hemoglobin A1c levels in the diabetic patients. As the A1c test reflects the average amount of glucose for the past two to three months, it is considered to be more reliable than traditional blood glucose tests. Due to increasing incidence of diabetes and growing awareness of better management of diabetes, the global hemoglobin A1c testing devices market is expected to develop rapidly in the years to come. Nowadays, medical professionals usually prescribe HbA1c test over conventional blood glucose tests to patients.
      In 2018, the global Hemoglobin A1c Monitoring market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Hemoglobin A1c Monitoring status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemoglobin A1c Monitoring development in United States, Europe and China.

      The key players covered in this study
      Bayer Healthcare Diabetes Care (US)
      Abbott Laboratories (US)
      Roche Diagnostics (Switzerland)
      Axis-Shield plc (UK)
      Beckman Coulter, Inc. (US)
      Bio-Rad Laboratories Inc (US)
      Diazyme Laboratories Inc. (US)
      EKF Diagnostics Holdings Plc (UK)
      HEMOCUE(r) AB (Sweden)
      Infopia Co. Ltd. (South Korea)
      Menarini Diagnostics Ltd. (UK)
      Siemens Healthcare Diagnostics (Germany)
      Tosoh Bioscience, Inc (US)
      Trinity Biotech plc (Ireland)
      ARKRAY, Inc. (Japan)

      Market segment by Type, the product can be split into
      Ion-exchange
      High-performance liquid chromatography (HPLC)
      Immunoassay
      Boronate affinity chromatography
      Direct enzymatic assay

      Market segment by Application, split into
      HbA1c Laboratory Testing
      HbA1c Point of Care Testing

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Hemoglobin A1c Monitoring status, future forecast, growth opportunity, key market and key players.
      To present the Hemoglobin A1c Monitoring development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Hemoglobin A1c Monitoring are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now